|Bid||0.0000 x 3000|
|Ask||0.0000 x 2200|
|Day's Range||1.5800 - 2.0000|
|52 Week Range||0.5300 - 5.5200|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Anthony Hayes has been the CEO of Spherix Incorporated (NASDAQ:SPEX) since 2013. This analysis aims first to contrast...
Benzinga Pro's Stocks To Watch For Monday * ExxonMobil (XOM) \- Shares were down nearly 14% as the price of crude oil fell more than $9/barrel. Saudi officials decided to instigate a price war by cutting production over the weekend. Crude oil last traded around $32/barrel. * SPDR Gold ETF (GLD) \- This ETF was up about 0.3% in opposition to the move in oil. Gold also benefited amid reports the number of coronavirus cases confirmed outside China nearly tripled since last week. * Boeing (BA) \- The stock was down about 9% following a report the FAA may require the company to fix electrical wire issues before the 737 MAX can return to flight. * Tesla (TSLA) \- A weekend article from the FT suggested notable investor James Anderson, head of global equities for Baillie Gifford (Tesla's largest shareholder), said he was now "more comfortable" with the company following a recent management shuffle. Anderson called the appointment of Robyn Denholm, an independent board member since 2014, a "decisive move." * Spherix (SPEX) \- A new coronavirus play as of Friday, shares continued higher Monday morning. After closing up 131% on Friday, shares were up another 60% Monday morning. On Friday, the company announced the execution of exclusive option deal with University of Maryland for "Methods of Treating Coronavirus Infection" patent.See more from Benzinga * Benzinga Pro's Top 5 Stocks To Watch For Tues., Feb. 18, 2020: AAPL, WMT, TSLA, FLR, SPWR * Benzinga Pro's Top 5 Stocks To Watch For Fri., Feb. 14, 2020: TSLA, ROKU, CRON, YELP, AMD * Benzinga Pro's Top 5 Stocks To Watch For Thurs., Feb. 13, 2020: FXI, TSLA, BABA, NIO, CAT(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Shares of Spherix Inc. soared 21% in active morning trading Friday, after the biotechnology company said it executed an exclusive option agreement with the University of Maryland, Baltimore for the technology in the patent for "Methods of Treating Coronavirus Infection." Trading volume swelled to 2.2 million shares, already more than the full-day average of 1.2 million shares. The company said the invention was made with support awarded by the National Institutes of Health, which has certain rights in the invention. Under terms of the option, Spherix said it has until the end of May to execute a license agreement for commercial development. The stock has lost 23% over the past three months, while the iShares Nasdaq Biotechnology ETF has slipped 2.5% and the S&P 500 has shed 6.9%.
Spherix Incorporated (Nasdaq: SPEX) announced today that additional patent coverage has been granted by the United States Patent & Trademark Office to the patent portfolio being acquired by Spherix, in the field of pancreatic cancer.
For Spherix Incorporated’s (NASDAQ:SPEX) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. SPEX is exposed toRead More...
In this article, I’m going to take a look at Spherix Incorporated’s (NASDAQ:SPEX) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subject among investors.Read More...
While small-cap stocks, such as Spherix Incorporated (NASDAQ:SPEX) with its market cap of US$9.13M, are popular for their explosive growth, investors should also be aware of their balance sheet toRead More...
Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess Spherix Incorporated’s (NASDAQ:SPEX) track record on a highRead More...